GRP and neoplasm: ProGRP is categorised into three molecular subtypes based on differences in partial amino acid residues, and they have a common C-terminal sequence of ProGRP Research experiments have provided evidence to support the claim that ProGRP can act as a new tumour marker for SCLC by indicating GRP's level and gene expression [13].